Comparison of linezolid activities under aerobic and anaerobic conditions against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium
- PMID: 12499223
- PMCID: PMC148952
- DOI: 10.1128/AAC.47.1.398-399.2003
Comparison of linezolid activities under aerobic and anaerobic conditions against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium
Abstract
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium were exposed to linezolid (MIC of 2 mg/liter) under aerobic or anaerobic conditions in an in vitro pharmacodynamic model. Drug concentration and half-life were adjusted to simulate clinical dosing (600 mg twice daily) of linezolid. Linezolid produced a 2-log(10) killing at 24 h, and rates of killing against each of these facultative organisms as measured by mean survival time appeared similar under aerobic and anaerobic conditions.
Figures
Similar articles
-
Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.J Chemother. 2003 Oct;15(5):442-8. doi: 10.1179/joc.2003.15.5.442. J Chemother. 2003. PMID: 14603881
-
In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.Microb Drug Resist. 2003 Winter;9(4):389-93. doi: 10.1089/107662903322762833. Microb Drug Resist. 2003. PMID: 15000746
-
In vitro activities of DA-7867, a novel oxazolidinone, against recent clinical isolates of aerobic and anaerobic bacteria.Antimicrob Agents Chemother. 2004 Jan;48(1):352-7. doi: 10.1128/AAC.48.1.352-357.2004. Antimicrob Agents Chemother. 2004. PMID: 14693566 Free PMC article.
-
Linezolid for the treatment of resistant gram-positive cocci.Ann Pharmacother. 2001 May;35(5):566-75. doi: 10.1345/aph.10276. Ann Pharmacother. 2001. PMID: 11346064 Review.
-
Pharmacological issues of linezolid: an updated critical review.Clin Pharmacokinet. 2010 Jul;49(7):439-47. doi: 10.2165/11319960-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20528004 Review.
Cited by
-
Development and Validation of an HPLC-UV Method for Quantitation of Linezolid: Application to Resistance Study Using in vitro PK/PD Model.Infect Drug Resist. 2021 Dec 1;14:5089-5098. doi: 10.2147/IDR.S343200. eCollection 2021. Infect Drug Resist. 2021. PMID: 34880634 Free PMC article.
-
Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.Antimicrob Agents Chemother. 2003 Dec;47(12):3789-94. doi: 10.1128/AAC.47.12.3789-3794.2003. Antimicrob Agents Chemother. 2003. PMID: 14638484 Free PMC article. Clinical Trial.
-
Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.Antimicrob Agents Chemother. 2004 Dec;48(12):4665-72. doi: 10.1128/AAC.48.12.4665-4672.2004. Antimicrob Agents Chemother. 2004. PMID: 15561842 Free PMC article.
-
Front-loaded linezolid regimens result in increased killing and suppression of the accessory gene regulator system of Staphylococcus aureus.Antimicrob Agents Chemother. 2012 Jul;56(7):3712-9. doi: 10.1128/AAC.05453-11. Epub 2012 Apr 23. Antimicrob Agents Chemother. 2012. PMID: 22526313 Free PMC article.
-
Pharmacokinetic/pharmacodynamic factors influencing emergence of resistance to linezolid in an in vitro model.Antimicrob Agents Chemother. 2007 Apr;51(4):1287-92. doi: 10.1128/AAC.01194-06. Epub 2007 Jan 22. Antimicrob Agents Chemother. 2007. PMID: 17242144 Free PMC article.
References
-
- Peterson, L. R., and D. N. Gerding. 1980. Influence of protein binding of antibiotics on serum pharmacokinetics and extravascular penetration: clinically useful concepts. Rev. Infect. Dis. 2:340-348. - PubMed
-
- Suller, M. T., and D. Lloyd. 2002. The antibacterial activity of vancomycin towards Staphylococcus aureus under aerobic and anaerobic conditions. J. Appl. Microbiol. 92:866-872. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources